Select Page

About Us Leadership Team

Daniel M. Hoefner, MT, PhD, DABCC, FACB

Dr. Hoefner is currently President, Laboratory Director, and Co-Founder of Salveo Diagnostics, Inc., a laboratory-based disease management company with a focus on major chronic diseases.

Dr. Hoefner’s laboratory career began in 1983 when he completed a Medical Technology program; subsequently, he earned a B.S. in Chemistry (Eastern Washington University) and Doctorate in Toxicology (University of Kentucky). During his academic endeavors, he continued his employment as a Medical Technologist with the goal of becoming credentialed as a clinical laboratory director. Toward this end, he completed a fellowship in Clinical Chemistry at the Mayo Clinic in Rochester.

After Mayo, he took a position as Clinical Scientist at Dade Behring where he was involved in the development and evaluation of clinical laboratory assays. This included the design and execution of field evaluations for new design plans, as required for FDA submissions and approval. Following that, he was Assistant Professor of Pathology at Dartmouth Medical School and also Assistant Director of the Dartmouth-Hitchcock Medical Center Laboratory and the Dartmouth Reference Laboratory. Subsequently, he was employed at LabCorp as corporate Director of Clinical Science Assessment where duties included global new method and instrument selection, defining and establishing overall standardization and harmonization processes, working with existing vendors to improve the quality of their products, and writing corporate policy and scientific papers. With a desire to get back into clinical operations, he took a position as Clinical Chemist at the Marshfield Clinic (~700 physicians) and eventually moved into the role of Chief Clinical Chemist. Responsibilities included laboratory directorship, consulting with physicians, new test evaluation, partnering with vendors and colleagues on R&D projects, and teaching.

In 2010, Dr. Hoefner joined the young start-up, Health Diagnostic Laboratory (HDL, Richmond, VA) as Director of Technology and Development. His responsibilities included providing technical and managerial direction for R&D, developing partnering relationships with vendors; ensuring compliance within CLIA’s and CAP’s regulatory guidelines. In 2013, he was promoted to Laboratory Director of HDL where he enjoyed great success in spear-heading his team to develop what became known as the ‘gold standard’ in cardiovascular and metabolic testing.  Since completing his fellowship at the Mayo Clinic, Dr. Hoefner has been team Leader or Member of numerous College of American Pathologists (CAP) inspections and continues to participate in multiple laboratory inspections every year.

Since 1989, he has been a member of the AACC and has served as Secretary, Treasurer, and Chair of the North Carolina local section. He also served two terms as the NC delegate to the House, has been on several task forces and steering committees in the House of Delegates, as well as Chair of the House in 2008. For many years, he was Information Officer of the Lipoproteins and Vascular Diseases Division (LVDD), producer of their newsletter and was Chair of the LVDD in 2010 & 2011.

Dr. Hoefner also served as a Member of AACC’s Strategies Editorial Advisory Board from 2009 – 2013; was a Member of the AACC Board of Directors in 2007 & 2008, and was a Member of the National Academy of Clinical Biochemistry (NACB) Awards Committee from 2007 – 2013.

Dr. Hoefner has co-authored more than 45 articles published in the peer-reviewed literature, primarily in the area of cardiometabolic disease, but also pertaining to tumor markers, erythrocyte rheology, method validation, as well as preanalytical issues related to specimen handling and analyte stability. On these same topics, he has lectured at numerous meetings across the United States and as far away as China.


Joseph P. McConnell, PhD, DABCC, FACB

Dr. McConnell is currently the CSO of Salveo Diagnostics, LLC, a laboratory based disease management company focused on assessment and prevention of chronic diseases including intestinal disease, autoimmune disease, cognitive decline and depression, bone disease, cardiovascular disease, diabetes, and fatty liver disease, stressing optimal male and female health in both the adult and pediatric sectors.

Prior to starting Salveo Diagnostics, LLC. Dr. McConnell spent nearly 12 years (Jan, 1998 – Oct, 2009) as Director of Cardiovascular Laboratory of Medicine at the Mayo Clinic and was Chair of the Mayo Clinical Chemistry Fellowship Program.  In 2009, Dr. McConnell co-founded Health Diagnostic Laboratory, Inc. (HDL, Inc.) and served as Chief Laboratory Officer until 2014, when he was appointed President and Chief Executive Officer.  He served in that position for 1 year before co-founding Salveo Diagnostics.    HDL, Inc. was focused on disease management in the areas of cardiovascular disease (CVD), diabetes mellitus (DM), and the metabolic syndrome (MS).

Dr. McConnell has authored more than 160 publications in peer-reviewed scientific literature, primarily in the field of atherosclerosis and the use of novel biomarkers to identify individuals at increased risk for developing cardiovascular disease, diabetes, and related chronic conditions, but has additionally published on other chronic diseases.  He holds a Bachelor’s degree in Biology from the University of Michigan, a Master’s degree in Chemistry and a Doctorate in Clinical Bioanalytical Chemistry from Cleveland State University.  He received his Clinical Chemistry post-doctorate training at the Mayo Clinic in Rochester, Minnesota.

Dr. McConnell has been active in the American Association for Clinical Chemistry (AACC) throughout his career and has collaborated extensively with esteemed cardiologists, endocrinologists, and other world-renowned researchers investigating cardiovascular diseases.   He has been the recipient of numerous awards and recognitions as well, including outstanding speaker awards from the American Association for Clinical Chemistry (AACC), a distinguished author award from the American Society for Clinical Laboratory Science (ASCLS), the Zak Award for outstanding contributions to scientific research in the area of lipoproteins and vascular diseases, and most recently the 2014 Cooper Award for outstanding service to the Lipoprotein and Vascular Diseases Division of the AACC.

He currently sits on the Boards of the American Heart Association-Richmond Chapter, the Foundation of Health Improvement and Technology (FHIT), and Grenova, LLC.  


Mark Chapman, CEO

Mr. Chapman has served as Chief Executive Officer of Salveo Diagnostics, Inc since joining the company in 2017. In his time at Salveo, the company’s mission has expanded to encompass 5 specific disciplines: (1) Leadership in the field of Diagnostics; (2) Expanded Scientific Testing; (3) Research; (4) Clinical Education in Laboratory Science, and (5) Better Medicine focused on the Root Cause and Prevention.

During Mr. Chapman’s tenure, Salveo has grown by over 420 percent in revenue and is on an accelerated growth curve that projects an additional 100 percent revenue growth by the end of 2019. Through his leadership, Salveo has also earned respect globally, recently partnering to open a Joint Venture in China.

Meanwhile Salveo, with its vertically-integrated laboratory and headquarters in Richmond, Virginia, has grown to employ over 80 people. With the help of Mark’s purpose-driven leadership, this group of highly trained experts in their field are aligned in passionate pursuit of a singular mission: to reverse the epidemic of chronic disease, one patient at a time.

Mark is also founder of Chapman Strategies, Inc., and PreActive Health Strategies, Inc., which specialize in leadership and operational effectiveness. In his early career Mr. Chapman held numerous leadership positions in four major fortune 500 consumer products companies and is a thought leader in the field of Leadership and Personalized Better Medicine.

Mr. Chapman has served as a consultant to multiple companies across several different industries as well as a government contractor. Mr. Chapman has over 100 CME’s from the Institute for Functional Medicine and for 2 years served as a volunteer in Pastoral Care at St. Luke’s Hospital located in Houston Texas. Mr. Chapman has served on several profit and non-profit boards as well as being a Court Appointed Child Advocate.


Anastasia Kurello Katany, DO, AAFP, ABAARM 


Dr. Katany is the Director of Clinical Education at Salveo Diagnostics, Inc. where she works with Salveo’s scientists, health coaches, and sales team to develop the clinical resources that help physicians and patients understand, best use, and act upon Salveo’s biomarker testing services.

Dr. Katany graduated from Philadelphia College of Osteopathic Medicine in 1994 and was Chief Intern for a year at Michigan State University/Mercy Health Partners, during which time she served as liaison for the then newly formed Consortium on Osteopathic Graduate Medical Education (COGMET).

After graduating from residency training in Family Medicine at the Medical College of Virginia/VCU in 1997, Dr. Katany practiced as a Family Physician for several years in Central Virginia, including 11 years at Carilion Physician Associates and Bedford Memorial Hospital in Bedford County. She also served as Physician for the Central Virginia Health District from Nov. 2004 to Jan. 2006. Her passion for education led her to teaching positions as Adjunct Professor at Lynchburg College Department of Biology (2002) and Preceptor of Family Medicine to 3rd and 4th-year medical students at University of Virginia School of Medicine (2001-2004) while maintaining a clinical practice. Dr. Katany also served as adjunct faculty for Old Dominion University as a preceptor for their nurse practitioner training program and serves as a Supervisor for the National Board for Certification of Nutrition Specialists. She is also a Diplomate of the Metabolic Medicine Institute.

Over time, Dr. Katany became concerned by the number of patients coming to her practice with recurring chronic conditions, and was increasingly frustrated with the limited repertoire of tools available to her through conventional medicine with which to truly help them heal. The story below about her daughter is a case in point, and a critical juncture that took her medical practice in a new direction. After years of intensive study and a 2-year advanced postdoctoral fellowship, Dr. Katany attained board certification in Integrative, Functional, and Regenerative Medicine in 2010 through Morsani College of Medicine. It was this year that Dr. Katany founded Inspire Health, her own Family and Functional Medicine practice in Forest, VA, where she remained CEO until 2015.